newsfilter
← Latest News
GlobeNewswire·

Chembio Diagnostics Submits EUA Application for New DPP SARS-CoV-2 Antigen Test

HAUPPAUGE, N.Y., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced the submission of an Emergency Use Authorization (EUA) application